Literature DB >> 32524164

Recommendations of protective measures for orthopedic surgeons during COVID-19 pandemic.

Yulong Wang1, Lian Zeng1, Sheng Yao1, Fengzhao Zhu1, Chaozong Liu2, Anna Di Laura2, Johann Henckel2, Zengwu Shao1, Michael T Hirschmann3, Alister Hart2, Xiaodong Guo4.   

Abstract

PURPOSE: It was the primary purpose of the present systematic review to identify the optimal protection measures during COVID-19 pandemic and provide guidance of protective measures for orthopedic surgeons. The secondary purpose was to report the protection experience of an orthopedic trauma center in Wuhan, China during the pandemic.
METHODS: A systematic search of the PubMed, Cochrane, Web of Science, Google Scholar was performed for studies about COVID-19, fracture, trauma, orthopedic, healthcare workers, protection, telemedicine. The appropriate protective measures for orthopedic surgeons and patients were reviewed (on-site first aid, emergency room, operating room, isolation wards, general ward, etc.) during the entire diagnosis and treatment process of traumatic patients.
RESULTS: Eighteen studies were included, and most studies (13/18) emphasized that orthopedic surgeons should pay attention to prevent cross-infection. Only four studies have reported in detail how orthopedic surgeons should be protected during surgery in the operating room. No detailed studies on multidisciplinary cooperation, strict protection, protection training, indications of emergency surgery, first aid on-site and protection in orthopedic wards were found.
CONCLUSION: Strict protection at every step in the patient pathway is important to reduce the risk of cross-infection. Lessons learnt from our experience provide some recommendations of protective measures during the entire diagnosis and treatment process of traumatic patients and help others to manage orthopedic patients with COVID-19, to reduce the risk of cross-infection between patients and to protect healthcare workers during work. LEVEL OF EVIDENCE: IV.

Entities:  

Keywords:  2019 novel coronavirus; 2019-nCoV; COVID-19; Cross-infection; Fracture; Novel coronavirus disease; Orthopedic surgery; Protection; Traumatology; Treatment and diagnosis

Mesh:

Year:  2020        PMID: 32524164      PMCID: PMC7283425          DOI: 10.1007/s00167-020-06092-4

Source DB:  PubMed          Journal:  Knee Surg Sports Traumatol Arthrosc        ISSN: 0942-2056            Impact factor:   4.342


Introduction

In December 2019, the Coronavirus Disease 2019 (COVID-19) caused by coronavirus (2019-nCoV) was found in Wuhan (Hubei, China) [44] and then became a worldwide pandemic on 11th March 2020. Compared with severe acute respiratory syndrome (SARS) coronavirus, COVID-19 has a lower mortality, but it is more infectious and pathogenic [4, 31, 36]. According to statistics from Johns Hopkins University [24], a total of 4,136,056 cases of COVID-19 have been confirmed globally until 11 May, 2020. Due to the high infectivity of 2019-nCoV, the source of infection can be COVID-19 patients and asymptomatic infected people. The main routes of transmission of 2019-nCoV are respiratory droplets, close contact and aerosol transmission [4, 17, 31-33, 36, 45]. Furthermore, COVID-19 has a latent period of 1–14 days, up to 24 days [17]. Therefore, in the process of patient treatment and diagnosis, there is a high risk of cross-infection to healthcare workers [19]. The pandemic of COVID-19 has brought great challenges at every step in the patient pathway, from pre-hospital, emergency diagnosis and treatment, emergency surgery, anesthesia, and perioperative management. In every step of treatment, the strategies for the treatment of trauma patients should be formulated and protective measures should be taken. What PPE should be worn, and what preventive steps should be undertaken by healthcare workers in different areas of the patient pathway? Hence, we performed the present systematic review that aimed to identify the optimal protection measures during COVID-19 pandemic and provide guidance of protective measures for orthopedic surgeons. The secondary purpose was to report the protection experience of an orthopedic trauma center in Wuhan, China. As of March 26, 2020, a total of 23,187 cases with COVID-19 including rescuing 1,134 cases of acute and critical illness and more than 400 patients with ventilators have been treated in our institution (Hubei, China) located in the center of the epidemic; meanwhile, various surgeries are performed in more than 300 cases with COVID-19. The Orthopedic Department has handled more than 260 emergency cases. Recommendations of protective measures was developed in a learning by doing and consensus process [14, 17, 20, 26, 31–33, 37, 42, 45, 48]. This paper also describes what was done and how it was implemented.

Materials and methods

A systematic review of the available literature was performed for articles published up to April 27, 2020 using the keyword terms “COVID-19”, “fracture”, “trauma”, “orthopedic”, “surgeon”, “healthcare workers”, “protection”, “telemedicine” in several combinations. The following databases were assessed: PubMed, Cochrane, Web of Science, Google Scholar, and all the publications were searched. The search was limited to English studies only. Studies in other languages were not included in this review.

Study selection

All peer-reviewed articles were considered. Randomized controlled trials (RCTs), prospective trials and retrospective studies as well as reviews and case reports were included in this systematic review. Two authors independently screened the titles and abstracts of all the articles were identified. If the abstract and the full-text was unavailable, the paper was excluded. In the event of disagreement, a consensus was reached by discussion, if needed with the intervention of the senior author. This systematic review was conducted in accordance with the established guidelines from Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA). However, due to the heterogeneity of available data, it was decided to present the review in a narrative manner.

Data extraction

One author extracted data from all the selected original articles, which was repeated by two other authors. If there was no agreement between the three, the senior author was consulted. Where required, the corresponding authors were contacted for additional information. This review focused on protective measures in the entire diagnosis and treatment process. At each stage of the literature search, a kappa value was calculated to determine inter-reviewer agreement on study selection. Pertinent information extracted included author, date and journal of publication, study design (and level of evidence). Descriptive statistics, such as the means, ranges, and measures of variance [e.g., standard deviations (SD)], are presented where applicable.

Results

The initial literature search found 176 articles. After removing 23 duplicates, 153 studies were screened. Of the 153 studies, 126 were excluded after screening of the title and abstract. Additional 9 studies were excluded after full-text review. Thus, 18 articles were finally eligible for data extraction. Agreement between the reviewers on study selection was substantial at the title review stage (k = 0.705; 95% CI 0.563–0.828), almost perfect at the abstract review stage (k = 0.871, 95% CI 0.475–0.999), and perfect at the full-text review stage (k = 1.0). Based on the analysis of levels of evidence, one study was classified as level III, fourteen studies were classified as level IV and the remaining three studies were classified as level V. Due to study design heterogeneity it was not possible to pool results across studies and perform a meta-analysis. Only one case series study reported 10 fracture patients (8 women and 2 men) with COVID-19, for which the mean age was 68.4 ± 17.5 years old (range 34–87). Eight (80%) with complications such as hypertension, diabetes, brain injury, etc., and 4 (40%) patients eventually died [29]. It indicated that enormous challenges to treat patients with traumatic fracture are given to orthopedic surgeons during COVID-19 pandemic. Many studies [1, 27, 28, 30, 39, 50] reported that using video or teleconference for morning rounds, electronic consultations, videoconferencing, digital outpatient and other telemedicine methods to provide medical guidance and follow-up instruction for patients can reduce unnecessary contact, limiting the spread of the virus and save protective materials. Two surveys of surgeons found that the kind of protective measures should be taken and how to or not to screen patients with COVID-19 are different in different countries or different departments [16, 30]. Another survey of COVID-19 disease among orthopedic surgeons from 8 hospitals in Wuhan found a total of 26 surgeons were diagnosed with COVID-19 [19], and the incidence varied from 1.5 to 20.7%. Training on prevention measures and wearing of respirator masks was found to be protective. Not wearing an N95 respirator was a risk factor for infection with COVID-19 as well as severe fatigue due to work overload [19]. Delaying and canceling elective surgery, and the exact definition of emergency surgery are still under debate [1, 11, 13, 14, 16, 27, 29, 37, 39, 42, 50]. Emergency surgery in the context of the current crisis can be defined as urgent pathologies that could result in long-term disability and/or chronic pain if surgery is postponed [14, 35, 37]. Trauma related fractures are the most common cause of emergency surgery [5, 6, 9, 12, 21, 23, 38, 47]. The WHO and evidence-based literature have not given any detailed recommendations for emergency orthopedic treatment during COVID-19 pandemic. There was no study concerning the management of an outpatient clinic and surgical activities and the challenges in handling with a high-volume practice during epidemic. Only one article offered important points and strategies to provide the highest level of safety to healthcare workers during the start-up phase [13]. Most studies (13/18) emphasized that orthopedic surgeons should pay attention to personal protection when facing the COVID-19 pandemic to prevent cross-infection [1, 11, 13, 14, 16, 19, 20, 27, 34, 35, 39, 42, 50]. Four studies have reported in more detail on personal protection [1, 11, 20, 35] (Table 1). There are no studies about the level of protection should be recommended for orthopedic surgeon from on-site emergency to patient discharge. Only Hirschmann et al. [20] gave an evidence-based recommendation on which PPE should be used to avoid occupational transmission of COVID-19 during surgery.
Table 1

Summaries of main points of the studies

AuthorsLevel of evidenceMain points of the studies
Hirschman et al.IVMake recommendations and detailed introduction for personal protective equipment and safety recommendations for orthopedic surgeons and trauma surgeons. Strict protective measures should be taken during surgery to avoid occupational transmission of COVID-19 to the surgical team by surgical aerosol
Rodrigues-Pinto et al.VShare their experience of management in the COIVD-19 dedicated operating room, and perform different sterile procedures in different zones of operating room to reduce the risk of cross-infection
Awad et al.IVProvide evidence-based recommendations and measures for the appropriate PPE in urgent surgical care. Recommended precautions and preventive actions in triage area, ED consultation room, induction room, operating room, and recovery room are reviewed
Coccolini et al.VEmphasize to choose the appropriate PPEs in the whole process of surgery from transfer COVID-19 patients to designated operating room to recovery room. All hospitals should organize dedicated protocols and workforce training as part of the effort to face the current pandemic
Summaries of main points of the studies

Discussion

During the COVID-19 pandemic, orthopedic patients as well as medical staff may be infected with COVID-19 when they are exposed to people infected with COVID-19 during their work. Transmission from medical staff to medical staff, patient to medical staff, as well as medical staff to patient, has been demonstrated. The most commonly suspected areas of exposure during the entire diagnosis and treatment process were general wards, followed by public places at the hospital, operating rooms, the intensive care unit, and the outpatient clinic [19]. To avoid occupational transmission of COVID-19 to medical staff, appropriate protective measures taken by orthopedic surgeons during pandemic in different sites from pre-hospital, emergency diagnosis and treatment, emergency surgery, anesthesia, and perioperative management are of great importance.

On-site first aid

In principle, all patients with fractures which occurred in pandemic areas should be treated as suspected COVID-19 cases [11, 35, 46]. The ambulance requires sufficient protective equipment and rescue equipment [32]. All medical personnel should be familiar with the symptoms of COVID-19 and should have received professional training in level-three personal protective equipment (PPE) [11, 19, 20, 29, 31, 34, 35, 45] (Table 2). In addition, all should be educated well in wearing and taking off a disposable hat, disposable protective clothing, long shoe cover, N95/FFP2 mask, goggles, double-layer gloves and protective face screen. PPE is important to minimize the chance of contact with body fluids of the wounded. Before arriving at the scene, all the healthcare workers and drivers involved in the pre-hospital emergency should take level-two PPE. For patients with contact with COVID-19 patients or exhibiting the symptoms of fever and/or respiratory symptoms, the pre-hospital emergency healthcare workers and drivers in the non-pandemic area should take level-two PPE in advance.
Table 2

Levels of PPE available

Protection levelPersonal protective equipment (PPE)
Level one

Disposable surgical cap

Disposable surgical mask

Work uniform

Disposable latex gloves or/and disposable isolation clothing if necessary

Level two

Disposable surgical cap

Medical protective mask (N95)

Work uniform

Disposable medical protective uniform

Disposable latex gloves

Goggles

Level three

Disposable surgical cap

Work uniform

Disposable medical protective uniform

Disposable latex gloves

Powered air purifying respirator (PAPR) or full-face respiratory protective devicesa

aDue to the limited quantity of PAPR, N95/FFP2 mask and full-face respiratory protective devices are sometimes used instead

Levels of PPE available Disposable surgical cap Disposable surgical mask Work uniform Disposable latex gloves or/and disposable isolation clothing if necessary Disposable surgical cap Medical protective mask (N95) Work uniform Disposable medical protective uniform Disposable latex gloves Goggles Disposable surgical cap Work uniform Disposable medical protective uniform Disposable latex gloves Powered air purifying respirator (PAPR) or full-face respiratory protective devicesa aDue to the limited quantity of PAPR, N95/FFP2 mask and full-face respiratory protective devices are sometimes used instead

Transportation of the trauma patient to hospital

In principle, all the injured patients should be transported to the nearest hospital with proper isolation facilities, adequate levels of PPE and the ability to diagnose and treat COVID-19 patients. The ambulance is exposed to high concentration of aerosol for a long time in a relatively closed environment, and must be cleaned and disinfected thoroughly [4, 17, 31–33, 45]. Negative pressure ambulances are preferred. Only patients with excluded infection of COVID-19 can be sent to the general emergency department, the rest should be sent to the COVID-19-designated hospital for treatment.

Protection of healthcare workers in the emergency room (ER)

All staff who receive patients with suspected or confirmed COVID-19 need at least level-two PPE in the emergency room (ER) [1, 11, 31, 35, 45] (Table 2). If the patient is unconscious, or his/her family members cannot describe the epidemiological history, the suspected cases shall be treated as COVID-19. During pandemic, all patients should be treated as suspected cases of COVID-19 (Table 3). Adequate PPE and disinfection of medical equipment is paramount [17, 32, 33, 45].
Table 3

Screening item for all patients admitted during the epidemic period of COVID-19

NumberScreening item
1The 2019-nCoV specific antibodies test
2A chest CT scan
3The 2019-nCoV nucleic acid testa

All patients admitted during the epidemic period of COVID-19 and caregivers should be screened by the 2019-nCoV specific antibodies test, chest CT scan, and the 2019-nCoV nucleic acid test

aThe 2019-nCoV nucleic acid test can be screened twice for patients on admission if the first is negative

Screening item for all patients admitted during the epidemic period of COVID-19 All patients admitted during the epidemic period of COVID-19 and caregivers should be screened by the 2019-nCoV specific antibodies test, chest CT scan, and the 2019-nCoV nucleic acid test aThe 2019-nCoV nucleic acid test can be screened twice for patients on admission if the first is negative

Diagnosis of COVID-19

If possible, the hospital personnel should take sputum, nasopharynx swab or blood samples using real-time fluorescent RT-PCR to rapidly detect viral nucleic acid or gene sequencing to make the final diagnosis. According to the guidelines [33], the physicians should make a suspected or confirmed diagnosis of COVID-19. If the patients who are sent to the emergency room are preliminarily assessed as suspected COVID-19, they might be transferred immediately to complete a chest CT scan [13, 31, 33]. All patients admitted should be screened for 2019-nCoV (Table 3) [13, 30, 31, 39], and COVID-19 needs to be differentiated from traumatic wet lung. In the pandemic area, the patients who do not need emergency surgery are admitted to the emergency buffer ward in single room isolation, and treated as suspected cases of COVID-19. After screening for COVID-19 (Table 3), COVID-19 negative patients can be transferred to the general ward in a single room, minimizing the number of family caregivers (at most 1 member) and forbidding other family members to visit [30, 39]. Caregivers should be screened for COVID-19 [14, 39] (Table 3), and must be negative. Confirmed cases can be admitted in the same negative-pressure isolation ward with multiple persons. Severe or critical patients can be admitted to the intensive care unit as soon as possible [31, 46].

Indications for emergency surgery

The criteria for emergency surgery is “threat to the patient’s life if surgery or procedure is not performed, threat of permanent dysfunction of an extremity or organ system, risk of metastasis or progression of staging, risk of rapidly worsening to severe symptoms” [27, 35, 37, 42]. The main indications for emergency surgery at our center are: trauma seriously endangering life or limb [5, 14, 22], such as fracture with hemorrhagic shock, suspected large blood vessel injuries and fracture with important organ injuries; Gustilo II–III open fractures, closed fracture with compartment syndrome, fracture with severe infection; unstable pelvic fractures and failure of closed reduction in dislocation of the hip joint with/without acetabular fracture [6, 8, 12, 38]; unstable spine fracture with spinal cord injury (AIS grade C or below), or progressive aggravation of neurological dysfunction with/without Spinal Cord Compartment Syndrome (SCCS) or Spinal Cord Intramedullary Hypertension (SCImH) [15, 23, 40, 47]. Patients with mild to moderate COVID-19 are treated as above, whereas those with severe COVID-19 are more likely to be treated non-operatively (Table 4). In other words, severe COVID-19 is a relative contraindication for emergency orthopedic surgery. Patients with critical COVID-19 or those who are intolerant to operation or anesthesia are an absolute contraindication [33, 35, 37, 46].
Table 4

Clinical classifications of patients with a confirmed diagnosis of COVID-19 and indications for emergency surgery

Clinical classificationsClinical symptomsIndication for emergency surgery
MildThe clinical symptoms are mild and no pneumonia manifestations can be found in imagingNo contra-indication due to COVID-19
ModeratePatients have symptoms such as fever and respiratory tract symptoms, etc. and pneumonia manifestations can be seen in imagingNo contra-indication due to COVID-19
SevereAdults who meet any of the following criteria: respiratory rate ≥ 30 breaths/min; oxygen saturation ≤ 93% at a rest state; arterial partial pressure of oxygen (PaO2)/oxygen concentration (FiO2) ≤ 300 mmHg. Patients with > 50% lesions progression within 24–48 h in lung imaging should be treated as severe casesRelative contraindication
CriticalMeeting any of the following criteria: occurrence of respiratory failure requiring mechanical ventilation; presence of shock; other organ failure that requires monitoring and treatment in the ICUAbsolute contraindication
Clinical classifications of patients with a confirmed diagnosis of COVID-19 and indications for emergency surgery

Emergency pre-operative plan

According to patient's condition, trauma, injury type, stability, neurological function, medical equipment and technical conditions, the purpose of operation should be completed in a single approach or minimally invasive surgery as far as possible [2, 6, 7, 9, 10, 18, 22]. The team should take measures to reduce the influence of time, trauma, hemorrhage and anesthesia on patients with COVID-19. Disposable surgical instruments should be used where possible and non-operative treatment should be strongly considered [26, 33].

Patient transfer to the operating room

The COVID-19 testing is difficult to get quickly enough in an emergency setting. All emergency patients are protected according to suspected or confirmed patients [1, 31, 35]. All medical personnel should take level-two protective measures, using the special transfer vehicle with disposable sheets to lead patients to transfer to the negative pressure operation room through a special channel and a special lift [1, 25, 31, 32, 35, 41, 48].

PPE in the operating room

The door of the operating room should be marked with a COVID-19 sign. Staff numbers should be minimized in the operating room [1, 11, 35]. Visitors to the OR should be restricted and medical personnel should not enter or leave the operating room to avoid interrupting the negative pressure. Level-three PPE is required in the operating room for all staff [31, 48, 49], except patrol nurses/runners who can use level-two PPE. The operating room must be in a state of negative pressure (− 5 Pa) before the operation [11, 13, 41, 43, 48]. The buffer room should be closed, and equipment should be minimized in the operating room. Staff wearing PPE in the operating room are forbidden to leave the operating room until the PPE has been removed and the operation has finished. Patients with non-generalized anesthesia should wear surgical masks throughout the operation [11, 34, 43, 48]. For patients under general anesthesia, a breathing filter should be installed between the anesthetic mask and the respiration loop, and a breathing filter should be installed at the inhalation and exhalation end of the anesthesia machine, respectively [41, 43, 48].

Operating room management

The high-efficiency particulate air (HEPA) filters must be in use and the room should have a negative pressure [35, 41, 43, 48]. After surgery, the room should be disinfected by spraying peracetic acid or hydrogen peroxide for more than two hours, and the laminar flow should be off and air supply closed. Sampling of the surfaces and air in the operation room should be tested by the hospital infection control team after the disinfection process. The next operation can be continued only after the monitoring results are qualified [33, 43, 48].

Prevention of surgical aerosol during surgery

Surgery using the electrocautery, ultrasonic bone knife, drill, pulsatile lavage and other powered equipment result in aerosolization of blood, bone, and tissue fluid [20]. COVID-19 is present in all body fluids and so will be present in this aerosol. Limitation of the use of these procedures will minimize the aerosol [20, 49]. Hirschmann et al. reported that orthopedic surgery in particular to the lower limb produces vast amounts of aerosols when high-speed power tools are used, and orthopedic surgeons should use FFP2-3 or N95-99 respirator masks [20]. The ability for the aerosol to cause infection of the surgical team is unknown and dependent on the PPE worn by the surgical team. Smoke generated should be removed by an aspirator (note that suction also generates an aerosol) [49]. During the operation, normal saline for flushing should be minimized, splashing of the patient's body fluids should be avoided, and the residue of the fluid should be reduced as much as possible to prevent the pollution of the surrounding environment [20, 49]. The surgical team need to cooperate closely to prevent smoke from electrocautery, splashing of the patient’s body fluid, and sharp instrument injury [1, 11, 35, 48].

Disinfection of surgical instruments

Surgical instruments that have been directly exposed to the patient's body fluid should be immediately scrubbed with 1000–2000 mg/L chlorine-containing preparation, and then placed into double-layer yellow medical waste bags, labeled with 2019-nCoV, and immediately inform the disinfection and supply center to take them away [32, 33].

Postoperative management

Medical staff are advised to take appropriate protective measures according to the patient with/without COVID-19 and the environment which they are exposed in their work (Table 5). Preoperative chest CT scan [13, 31, 46] is an important investigation for clinical diagnosis of COVID-19, as well as diagnosing lung injury caused by high-energy trauma. Nevertheless, nucleic acid testing for COVID-19 or virus sequencing should be done as soon as possible after surgery. The body temperature of patients should be monitored at least three times a day after operation. For patients with COVID-19, wound infection should not be judged only by the results of blood tests and body temperature [3]. Consider whether fever is caused by a wound infection or COVID-19 [46].
Table 5

What PPE should be worn, and what steps done, by healthcare workers in different areas of the patient pathway (prehospital, emergency room, inpatient ward, OR, outpatients)

SitesPrior to COVID-19 pandemicDuring a COVID-19 pandemicSpecific advice/important knowledge
No history of epidemic exposureEpidemiological exposure history
On-site first aidLevel oneLevel twoLevel two

Beware: all body fluids can contain COVID-19 virus (vomit, urine, blood, sputum)

When in a pandemic, all patients are suspected of having COVID-19

AmbulanceLevel oneLevel twoLevel two

Beware: the ambulance environment receives a high level of aerosol

Negative pressure ambulances are preferred

Emergency roomLevel oneLevel twoLevel two

Test for COVID-19 ASAP

CT scan chest for all (appearances of COVID-19 are different to traumatic wet lung)

Infection staff needed as part of the trauma team

Patient transfer in hospitalLevel oneLevel twoLevel twoUse special transfer, a special channel and a special lift
Operating roomLevel oneLevel twoLevel three

Severe COVID-19 is a relative contra indication to emergency orthopedic surgery and critical COVID-19 is an absolute contra indication

Level 3 PPE for all staff except runners who are level-two

Label door with COVID-19

Minimal staff numbers in the OR

Conversion of a positive pressure to a negative pressure of − 5 Pa should be confirmed prior to starting surgery

All patients should have masks if awake or exhaust filters if under general anesthesia

Remove the smoke from electrocautery quickly. Reduce irrigation. Minimize splashing of the patient’s body fluid

Hand disinfection is done before removing PPE

Isolation wardsLevel twoLevel twoLevel twoBeware: a high level of aerosol when performing high-risk procedures such as sampling from respiratory tract, intubation, tracheotomy, CPR, and etc., Level three PPE is required
General wardsLevel oneLevel oneLevel one

Pay attention to body temperature, respiratory symptom, and screening when necessary

Small probability that incubation period may be as long as 24 days

OutpatientsLevel oneLevel twoLevel two

Online outpatient clinic is preferred

Pay attention to body temperature, respiratory symptom and epidemiological exposure history

Pay attention to the possibility of positive viral etiology test results in patients recovered from COVID-19

What PPE should be worn, and what steps done, by healthcare workers in different areas of the patient pathway (prehospital, emergency room, inpatient ward, OR, outpatients) Beware: all body fluids can contain COVID-19 virus (vomit, urine, blood, sputum) When in a pandemic, all patients are suspected of having COVID-19 Beware: the ambulance environment receives a high level of aerosol Negative pressure ambulances are preferred Test for COVID-19 ASAP CT scan chest for all (appearances of COVID-19 are different to traumatic wet lung) Infection staff needed as part of the trauma team Severe COVID-19 is a relative contra indication to emergency orthopedic surgery and critical COVID-19 is an absolute contra indication Level 3 PPE for all staff except runners who are level-two Label door with COVID-19 Minimal staff numbers in the OR Conversion of a positive pressure to a negative pressure of − 5 Pa should be confirmed prior to starting surgery All patients should have masks if awake or exhaust filters if under general anesthesia Remove the smoke from electrocautery quickly. Reduce irrigation. Minimize splashing of the patient’s body fluid Hand disinfection is done before removing PPE Pay attention to body temperature, respiratory symptom, and screening when necessary Small probability that incubation period may be as long as 24 days Online outpatient clinic is preferred Pay attention to body temperature, respiratory symptom and epidemiological exposure history Pay attention to the possibility of positive viral etiology test results in patients recovered from COVID-19

Management of elective surgery

For patients undergoing a routine operation, if COVID-19 has been excluded, the surgery should be arranged with the normal treatment procedure according to the patient's priority; healthcare workers should take level 1 protective measures at least during surgery. For patients with surgery contraindicated in the early stage or other reasons such as conservative treatment failure, fear of hospitalization during the pandemic, etc., surgery can be performed according to treatment experience for delayed union [10, 25], referring to the aforementioned protective measures. During the transition period, it is necessary to strengthen the monitoring and protection of patients and family caregivers [13, 30, 39].

Discharge and post-discharge management

For patients without COVID-19, discharge should be scheduled time after surgery to reduce cross-infection in the hospital [31, 34]. After being discharged from the hospital, an online outpatient clinic or telemedicine can be used to guide the patient's follow-up treatment [1, 27, 28, 30, 39, 50]. At the same time, it is necessary to continue to strengthen the monitoring and protection of patients and family caregivers, and pay attention to the possibility of positive viral etiology test results in patients recovered from COVID-19 [14, 26, 31, 46].

Conclusion

Strict protection at every step in the patient pathway is important to reduce the risk of cross-infection during pandemic. Lessons learnt from our experience provide some recommendations of protective measures during the entire diagnosis and treatment process of traumatic patients and help others to manage orthopedic patients with COVID-19, to reduce the risk of cross-infection between patients and to protect healthcare workers during work.
  38 in total

1.  Single Modified Ilioinguinal Approach for the Treatment of Acetabular Fractures Involving Both Columns.

Authors:  Kaifang Chen; Yanhui Ji; Zhenfei Huang; Ramphul Navinduth; Fan Yang; Tingfang Sun; Zekang Xiong; Sheng Yao; Jaimo Ahn; Xiaodong Guo
Journal:  J Orthop Trauma       Date:  2018-11       Impact factor: 2.512

2.  COVID-19: Initial experience of an international group of hand surgeons.

Authors:  F Ducournau; M Arianni; S Awwad; E-M Baur; J-Y Beaulieu; M Bouloudhnine; M Caloia; K Chagar; Z Chen; A Y Chin; E C Chow; T Cobb; Y David; P J Delgado; M Woon Man Fok; R French; I Golubev; J R Haugstvedt; S Ichihara; R A Jorquera; S C J J Koo; J Y Lee; Y K Lee; Y J Lee; B Liu; T Kaleli; G R Mantovani; C Mathoulin; J C Messina; C Muccioli; S Nazerani; C Y Ng; M C Obdeijn; L Van Overstraeten; T O H Prasetyono; M Ross; J T Shih; N Smith; F A Suarez R; P-T Chan; H Tiemdjo; A Wahegaonkar; M C Wells; W-Y Wong; F Wu; X F Yang; D Yanni; J Yao; P A Liverneaux
Journal:  Hand Surg Rehabil       Date:  2020-04-09       Impact factor: 0.969

3.  The Orthopaedic Trauma Service and COVID-19: Practice Considerations to Optimize Outcomes and Limit Exposure.

Authors:  Daniel J Stinner; Christopher Lebrun; Joseph R Hsu; A Alex Jahangir; Hassan R Mir
Journal:  J Orthop Trauma       Date:  2020-07       Impact factor: 2.512

Review 4.  COVID-19 coronavirus: recommended personal protective equipment for the orthopaedic and trauma surgeon.

Authors:  Michael T Hirschmann; Alister Hart; Johann Henckel; Patrick Sadoghi; Romain Seil; Caroline Mouton
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2020-04-27       Impact factor: 4.342

5.  COVID-19 and spinal cord injury and disease: results of an international survey.

Authors:  Michael D Stillman; Maclain Capron; Marcalee Alexander; Melina Longoni Di Giusto; Giorgio Scivoletto
Journal:  Spinal Cord Ser Cases       Date:  2020-04-15

6.  Management of orthopaedic and traumatology patients during the Coronavirus disease (COVID-19) pandemic in northern Italy.

Authors:  Pietro Simone Randelli; Riccardo Compagnoni
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2020-04-25       Impact factor: 4.342

Review 7.  A Review of State Guidelines for Elective Orthopaedic Procedures During the COVID-19 Outbreak.

Authors:  Nikolas J Sarac; Benjamin A Sarac; Anna R Schoenbrunner; Jeffrey E Janis; Ryan K Harrison; Laura S Phieffer; Carmen E Quatman; Thuan V Ly
Journal:  J Bone Joint Surg Am       Date:  2020-06-03       Impact factor: 5.284

8.  Novel Coronavirus COVID-19: Current Evidence and Evolving Strategies.

Authors:  Christopher Vannabouathong; Tahira Devji; Seper Ekhtiari; Yaping Chang; Steven A Phillips; Meng Zhu; Zain Chagla; Cheryl Main; Mohit Bhandari
Journal:  J Bone Joint Surg Am       Date:  2020-05-06       Impact factor: 5.284

9.  Survey of COVID-19 Disease Among Orthopaedic Surgeons in Wuhan, People's Republic of China.

Authors:  Xiaodong Guo; Jiedong Wang; Dong Hu; Lisha Wu; Li Gu; Yang Wang; Jingjing Zhao; Lian Zeng; Jianduan Zhang; Yongchao Wu
Journal:  J Bone Joint Surg Am       Date:  2020-05-20       Impact factor: 6.558

10.  Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.

Authors:  Zunyou Wu; Jennifer M McGoogan
Journal:  JAMA       Date:  2020-04-07       Impact factor: 56.272

View more
  13 in total

1.  Hospital transmission rates of the SARS-CoV 2 disease amongst orthopaedic in-patients in a secondary care centre: A quantitative review.

Authors:  Natalie Holmes; Siddharth Virani; Jai Relwani
Journal:  J Clin Orthop Trauma       Date:  2021-01-13

2.  Orthopaedic Practices and Surgeries during COVID-19 in Pakistan - A Survey Based Study.

Authors:  M Saad-Ilyas; U Zehra; U U Khan; I Mohammad; R Muhammad; A Aziz
Journal:  Malays Orthop J       Date:  2021-03

3.  Correct Use of Facemask Among Health Professionals in the Context of Coronavirus Disease (COVID-19).

Authors:  Yohannes Tekalegn; Biniyam Sahiledengle; Kebebe Bekele; Abdi Tesemma; Tesfaye Aseffa; Zinash Teferu Engida; Alemu Girma; Alelign Tasew; Demisu Zenbaba; Rameto Aman; Kenbon Seyoum; Demelash Woldeyohannes; Birhan Legese
Journal:  Risk Manag Healthc Policy       Date:  2020-12-15

4.  The impact of COVID-19 on hand surgery: A French retrospective comparative study in COVID-19 and non-COVID-19 hand trauma centers.

Authors:  Inès Regas; Marine Pichonnat; Isabelle Pluvy; Laurent Obert; Philippe Bellemère; Camilo Chaves; François Loisel
Journal:  Orthop Traumatol Surg Res       Date:  2021-10-14       Impact factor: 2.425

5.  History of COVID-19 Was Not Associated With Length of Stay or In-Hospital Complications After Elective Lower Extremity Joint Replacement.

Authors:  Anna Jungwirth-Weinberger; Friedrich Boettner; Milan Kapadia; Alioune Diane; Yu-Fen Chiu; Stephen Lyman; Mark Alan Fontana; Andy O Miller
Journal:  Arthroplast Today       Date:  2021-12-10

6.  [The impact of COVID-19 on hand surgery: a French retrospective comparative study in COVID-19 and non-COVID-19 hand trauma centers].

Authors:  Inès Regas; Marine Pichonnat; Isabelle Pluvy; Laurent Obert; Philippe Bellemère; Camilo Chaves; François Loisel
Journal:        Date:  2021-10-15

7.  Clinical Activities, Contaminations of Surgeons and Cooperation with Health Authorities in 14 Orthopedic Departments in North Italy during the Most Acute Phase of Covid-19 Pandemic.

Authors:  Alessandro Aprato; Nicola Guindani; Alessandro Massè; Claudio C Castelli; Alessandra Cipolla; Delia Antognazza; Francesco Benazzo; Federico Bove; Alessandro Casiraghi; Fabio Catani; Dante Dallari; Rocco D'Apolito; Massimo Franceschini; Alberto Momoli; Flavio Ravasi; Fabrizio Rivera; Luigi Zagra; Giovanni Zatti; Fabio D'Angelo
Journal:  Int J Environ Res Public Health       Date:  2021-05-17       Impact factor: 3.390

8.  Developmental dysplasia of the hip screening during the lockdown for COVID-19: experience from Northern Italy.

Authors:  Nicola Guindani; Maurizio De Pellegrin
Journal:  J Child Orthop       Date:  2021-06-01       Impact factor: 1.548

Review 9.  Orthopaedic operating room considerations in covid-19 pandemic: A systematic review.

Authors:  Verma Tarun; Tiwari Anurag; Karkhur Yugal; Kumar Raj; Maini Lalit
Journal:  J Arthrosc Jt Surg       Date:  2021-02-23

10.  Telemedicine trends in orthopaedics and trauma during the COVID-19 pandemic: A bibliometric analysis and review.

Authors:  Arvind Kumar; Siddhartha Sinha; Javed Jameel; Sandeep Kumar
Journal:  J Taibah Univ Med Sci       Date:  2021-10-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.